Intermittent FDG uptake in lipomatous hypertrophy of the interatrial septum on serial PET/CT scans

Clinical Nuclear Medicine

Volumn 33, Issue 9, 2008, Pages 602-605

  Gerard, Perry S ^a,b   Finestone, Howard ^a   Lazzaro, Richard ^b   Geller, Matthew D ^a  

^a Division of Nuclear Medicine   (United States)

^b MAIMONIDES MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; ESOPHAGUS CARCINOMA; HEART ATRIUM HYPERTROPHY; HEART ATRIUM SEPTUM; POSITRON EMISSION TOMOGRAPHY; AGED; CANCER STAGING; CARCINOMA; CARDIOMEGALY; CASE REPORT; DIFFERENTIAL DIAGNOSIS; ESOPHAGUS TUMOR; HEART VENTRICLE SEPTUM; HUMAN; LIPOMA; MALE; METABOLISM; PATHOLOGY; RADIOGRAPHY; SCINTISCANNING; TIME;

AGED; CARCINOMA; CARDIOMEGALY; DIAGNOSIS, DIFFERENTIAL; ESOPHAGEAL NEOPLASMS; FLUORODEOXYGLUCOSE F18; HEART SEPTUM; HUMANS; LIPOMA; MALE; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 55449096389     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e318181312a     Document Type: Article

References (15)

1. Fan CM, Fischman AJ, Kwek BH, et al. Lipomatous hypertrophy of the interatrial septum: increased uptake on FDG PET. Am J Roentgenol. 2005;184:339-342.
2. Kuester LB, Fischman AJ, Fan CM. Lipomatous hypertrophy of the inter-atrial septum: prevalence and features on fusion 18F fluorodeoxyglucose positron emission tomography/CT. Chest. 2005;128:3888-3893.
3. Sarji AS. Physiological uptake in FDG PET simulating disease. Biomed Imaging Interv J. 2006;2:e59.
4. Popova NL, Kolobaev AV. Diagnostic difficulties in secondary tumors of the heart. Ter Arkh. 1990;62:71-72.
5. Mukhtar O, Miller A, Nanda NC, et al. Transesophageal echocardio-graphic findings of an intracavitary cardiac metastasis from a neuroen-docrine thymic carcinoma. Echocardiography. 2001;18:25-28.
6. Bruzzi JF, Munden RF, Truong MT, et al. PET/CT of esophageal cancer: its role in clinical management. Radiographics. 2007;27:1635-1652.
7. Meaney JFM, Kazerooni EA, Jamadar DA, et al. CT appearance of lipomatous hypertrophy of the interatrial septum. Am J Roentgenol. 1997;168:1081-1084.
8. Breuer M, Wippermann J, Franke U, et al. Lipomatous hypertrophy of the interatrial septum and upper right atrial inflow obstruction. Eur J Cardiothorac Surg. 2002;22:1023-1025.
9. Moinuddeen K, Marica S, Clausi RL, et al. Lipomatous interatrial septal hypertrophy: an unusual cause of intracardiac mass. Eur J Cardiothorac Surg. 2002;22:468-469.
10. O'Connor S, Recavarren R, Nichols LC, et al. Lipomatous hypertrophy of the interatrial septum: an overview. Arch Pathol Lab Med. 2006;130: 397-399.
11. Burke AP, Litovsky S, Virmani R. Lipomatous hypertrophy of the atrial septum presenting as a right atrial mass. Am J Surg Pathol. 1996;20: 678-685.
12. Del Mar Gonzalez-Barroso M, Ricquier D, Cas-sard-Doulcier AM. The human uncoupling protein-1 gene (UCP1): present status and perspectives in obesity research. Obes Rev. 2000;1:61-72.
13. Kawashita NH, Brito MN, Brito SR, et al. Glucose uptake, glucose transporter GLUT4, and glycolytic enzymes in brown adipose tissue from rats adapted to a high-protein diet. Metabolism..2002;51:1501-1505.
14. Truong MT, Erasmus JJ, Munden RF, et al. Focal FDG uptake in mediastinal brown fat mimicking malignancy: a potential pitfall resolved on PET/CT. Am J Roentgenol. 2004;183:1127-1132.
15. Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev. 2004;84:277-359.